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SAXSrBPI21 belongs to the antimicrobial peptide and protein (AMP) family. It has high afﬁnity for lipopolysaccha-
ride (LPS), acting mainly against Gram-negative bacteria. This work intends to elucidate the mechanism of
action of rBPI21 at the membrane level. Using isothermal titration calorimetry, we observed that rBPI21 inter-
action occurs only with negatively charged membranes (mimicking bacterial membranes) and is entropically
driven. Differential scanning calorimetry shows that membrane interaction with rBPI21 is followed by an
increase of rigidity on negatively charged membrane, which is corroborated by small angle X-ray scattering
(SAXS). Additionally, SAXS data reveal that rBPI21 promotes the multilamellarization of negatively charged
membranes. The results support the proposed model for rBPI21 action: ﬁrst it may interact with LPS at the
bacterial surface. This entropic interaction could cause the release of ions that maintain the packed structure
of LPS, ensuring peptide penetration. Then, rBPI21 may interact with the negatively charged leaﬂets of the
outer and inner membranes, promoting the interaction between the two bacterial membranes, ultimately
leading to cell death.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Bacterial resistance is considered by the World Health Organiza-
tion as “a major concern because a resistant infection may kill, can
spread to others, and imposes huge costs to individuals and society”
[1]. Antimicrobial peptides and proteins (AMPs) are part of the innate
immune system and a good alternative to conventional therapies
[2–4]. They are also a good approach to overcome bacterial resistance,
due to the lower opposition of bacteria against AMP mechanisms of
action at the membrane level [4]. Most AMPs possess a positive net
charge, which ensures the interaction with the negatively charged
bacterial surface. Bacterial membranes present high percentages
of negatively charged phospholipids [5–7]. In both Gram-positive
and Gram-negative bacteria, the major phospholipid componentss; BPI, bactericidal/permeability-
etry; ITC, isothermal titration
r vesicles;MCT,Modiﬁed Caillé
ray scattering
as, Instituto de Medicina Mo-
Av. Prof. Egas Moniz, 1649-028
999477.
rights reserved.are phosphatidylethanolamine (POPE), phosphatidylglycerol (POPG;
negatively charged) and cardiolipin (CL) [5,6].
rBPI21 is a protein fragment of 21 kDa, corresponding to the
N-terminal 193 amino acid residues of the bactericidal/permeability-
increasing protein (BPI), with a C132A point mutation [8]. This mole-
cule revealed bactericidal effects, mainly against Gram-negative bac-
teria, together with lipopolysaccharide (LPS) neutralization [9,10].
LPS, a negatively charged molecule present in the outer leaﬂet of the
outer membrane of Gram-negative bacteria, is responsible for severe
health conditions. When an infection occurs, Gram-negative bacteria
release LPS aggregates into the bloodstream. It interacts preferentially
withmonocytes andmacrophages, promoting the release of cytokines
[11,12]. The overproduction of these cytokines has several harmful
effects, associated with septicemia and with lethal septic shock [13].
Thus, it is necessary to ﬁnd new antibiotics that exert cytotoxic effects
on bacteria and, at the same time, possess LPS-neutralization proper-
ties. Due to its higher afﬁnity for LPS and consequent neutralization,
together with its bactericidal effects, rBPI21 has shown encouraging
clinical beneﬁts in severe forms of sepsis, including meningococcal
septic shock [14].
Some studies of the interaction between rBPI21 and membranes
have been reported [15–18], most of them focused on its interaction
with lipid membranes of different compositions, but little was shown
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are affected, leading to a high instability that culminates in its rupture,
as measured by membrane leakage experiments [15]. In order to
overcome the lack of information at this level, in the present study we
used small angle X-ray scattering (SAXS) and differential scanning
calorimetry (DSC) to evaluate the properties of membranes affected
by the presence of the peptide. Additionally, isothermal titration calo-
rimetry (ITC) was used to evaluate the preference of the peptide for
biomembrane model systems with different compositions. The results
obtained reinforce a hypothetical model for the mechanism of action
of rBPI21 at the molecular level previously proposed by some of us [15].
2. Materials and methods
2.1. Large unilamellar vesicles and lipopolysaccharide aggregates preparation
For the SAXS and ITC measurements, large unilamellar vesicles
(LUV) with ~100 nm diameter were obtained by extrusion of
multilamellar vesicles (MLV) [19]. Brieﬂy, the lipids were dissolved
in chloroform and dried under nitrogen ﬂux in a round bottom
ﬂask. The ﬂasks were dried overnight in vacuum, to remove any
remaining traces of chloroform. Then, the lipid ﬁlm was hydrated
with buffer and subjected to several freeze and thaw (above the lipids
phase transition temperatures) cycles. After complete hydration,
the lipid suspension was extruded by passing it several times
through ﬁlters with 100 nm pore size. For DSC measurements, MLV




were obtained from Avanti Polar Lipids (Alabaster, AL). LPS from
Escherichia coli (serotype O26:B6), with a molecular mass of 13 kDa,
as determined by Mangoni et al. [20], was from Sigma-Aldrich (St.
Louis, MO). The LUV studied were either zwitterionic (pure POPC) or
anionic (POPC:POPG 80:20, 70:30, 55:45 or 30:70, w:w). Stock solu-
tions of LPS aggregates were bath sonicated at 40 °C, during 20 min,
and kept at 4 °C overnight before measurements.
2.2. Isothermal titration calorimetry
All measurements were carried out in a Microcal VP-ITC microcalo-
rimeter (Microcal Inc./GE Healthcare Bio-Sciences, Northampton, MA,
USA). The VP-ITC was electrically calibrated by the manufacturer.
Peptide and lipid solutions in 20 mMTris–HCl buffer pH 7.4, containing
150 mM NaCl, were degassed under vacuum and thermostatized at
different temperatures (5, 15, and 25 °C) before measurement. The
reference power was set to 20 μcal/s, using a syringe stirring speed
of 242 rpm. The heat of dilution for successive injections of the lipid
suspension into Tris–HCl buffer was insigniﬁcant as compared to that
of peptide–lipid reaction. Although the dilution heat was negligible, it
was included in the ﬁnal analysis. The lipid concentration was 5 mM
for all lipid systems used, with the exception of 1 mM for POPC:POPG
30:70. The rBPI21 concentration in the reaction cell was 5 μM. The
heat developed from successive injections of the lipid was determined
by integrating the area under each titration peak, using the Origin soft-
ware provided by themanufacturer. Under the assumption of a one-site
binding model [21], with the ligand in the sample cell, the variations of
the thermodynamic parameters enthalpy (ΔH) and entropy (ΔS) were
calculated, as well as the equilibrium dissociation constant (KD). Due to
data signal-to-noise ratio limitations, it could not be successfully ﬁtted
with the model derived to quantify membrane partition [22,23].
2.3. Differential scanning calorimetry
All measurements were carried out with a Microcal VP-DSC calo-
rimeter (Microcal Inc./GE Healthcare Bio-Sciences, Nothampton, MA,USA). MLV were used for these experiments. Both DPPC and DPPG
were dissolved in a CHCl3:CH3OH 2:1 (v:v) mixture. The solutions of
DPPC and DPPC:DPPG 55:45 were dried under a stream of nitrogen
and then under high vacuum overnight. Tris–HCl buffer alone or
with different rBPI21 concentrations (5, 10, and 20 μM) was added
to each sample, during the hydration process, and vortexed. The
ﬁnal concentration of the lipid suspensions was 2 mM. Suspensions
were degassed under vacuum for 10 min before the DSC measure-
ments. A total of 8 scans were measured for each membrane compo-
sition at a scan rate of 10 °C/h. Data acquisition and analysis were
done using the Origin software.
2.4. Small angle X-ray scattering
SAXS measurements were performed with 5 mM POPC or POPC:
POPG (80:20 or 55:45) in 20 mM sodium phosphate buffer, pH 7.4,
containing 150 mM NaCl. These suspensions were incubated for
10 min in the absence and presence of three concentrations of rBPI21
(5 μM, 10 μM and 20 μM). SAXS experiments were performed at
the National Synchrotron Light Laboratory (LNLS), Campinas, Brazil,
using a detector-to-sample distance of ~950 mm. The scattering vector
amplitude, q, deﬁned as q ¼ 4π sinθλ (2θ being the scattering angle and λ
the X-ray wavelength of 1.488 Å), ranged from qmin = 0.02 Å−1 to
qmax = 0.33 Å−1. The experimental intensities were corrected for
background, buffer contributions, sample's attenuation and detector
homogeneity. SAXS measurements from rBPI21 up to 20 μM in buffer
solution resulted in no detectable signal.
As it will be shown in the Results and discussion, the presence
of rBPI21 induces the formation of some MLV coexisting in solution
with LUV. Thus, the SAXS intensity I(q) can be written as:
I qð Þ ¼ k w1P qð ÞS qð Þ þw2P qð Þð Þ ð1Þ
where k is related to the experimental setup, and wi is the weight
of each contribution (MLV or LUV) on I(q). P(q) corresponds to the
unilamellar vesicle form factor, such that [24–26]:
P qð Þ ¼ 2πA
q2
Pt qð Þ ð2Þ
where A is the area of the basal plane and Pt(q) is the form factor of
the bilayer cross-section (perpendicular to the basal plane) consid-
ered to be much smaller than the size of plane A [24]. Pt(q) is thus
known as the cross-section form factor, and it can be modeled by
assuming that the membrane is composed by three layers of different
electron densities in respect to the solvent (ρsol = 0.33 e/Å3 for
aqueous solution), namely: polar headgroup, with thickness Rpol and
electron density ρpol, parafﬁnic chains, with length Rpar and electron
density ρpar, and the methyl chain with RCH3 and ρCH3 [27]. This
way, Pt(q) is written as:
Pt qð Þ ¼
2
q




þ Δρpol sinq Rpol þ Rpar þ RCH3
 h
− sinq Rpar þ RCH3
 iog2 ð3Þ
withΔρCH3 = ρCH3 − ρsol, Δρpol = ρpol − ρsol and Δρpar = ρpar − ρsol.
The lipid bilayer thickness is, thus, 2(Rpol + Rpar + RCH3). During
the ﬁtting procedure, some of these parameters were allowed to vary
within a narrow range: RCH3 (2.0 Å b RCH3 b 3.5 Å), ρCH3 (0.15 e/Å
3 b
ρCH3 b 0.20 e/Å
3) and ρpar (0.25 e/Å3 b ρpar b 0.30 e/Å3), in accordance
with data from the literature [27]. The other Pt(q) parameters were
allowed to vary in a corresponding broader range.
In Eq. (1), S(q) is the so-called “measured” structure factor, which
is equal to 1 for non-interacting systems. In the case of multilamellar
stacking of bilayers, we made use of the well-known Modiﬁed Caillé
Theory (MCT) [24,28–30], which accounts for the ﬂuctuation of the
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[24,29,30]. Note that ηCaillé is related to the mean ﬂuctuation of the
lipid membrane such that [30]:
S qð Þ ¼ N þ 2
XN−1
n¼1






` ¼ 0:087ηCaille` D
2
Lamella ð5Þ
where σCaillé is the mean-square nearest neighbor distance ﬂuctua-
tions, which can give a rough information about the statistical be-
havior of the interacting bilayers, N is the number of oriented bilayers,
and DLamella is the repeating unit between the lamella. Noteworthy,
such methodology is related to the bilayer ﬂuctuation and does not
take into account any direct interaction potential. Furthermore, it is im-
portant to mention that ηCaillé is related to the bending modulus, K, and
also to the bulkmodulus for compression, B, of the lipid bilayers [28,29].
Thus, during the ﬁttings to the experimental data, four other parame-
ters were varied,N, σCaillé, ηCaillé andDLamella, related to the S(q) function
on Eqs. (1) and (4). All SAXS data ﬁtting procedure were performed
using a Global ﬁttingmethodology (GENFIT software), as previously de-
scribed [31–34].
3. Results and discussion
3.1. Isothermal titration calorimetry
ITC was used in order to evaluate and compare the preference of
the rBPI21 for different membrane systems. The extension of the inter-
action was not possible to quantify through a partition model [22,23]
due to data quality limitations. However, experimental data were
ﬁtted to a “one-site” binding model in order to assess the interaction
thermodynamics (Table 1). The calculation of the thermodynamic pa-
rameters through this binding model needs to be interpreted with
caution, since AMP–membrane interactions are often more complex
than a single site binding isotherm [35,36]. POPC:POPG mixtures
were used as model systems to mimic the negatively charged mem-
branes of Gram-negative bacteria. On the other hand, the zwitterionic
POPC system was used as a model for eukaryotic membranes.
Most of the interactions present a heat ﬂow proﬁle showing an en-
dothermic reaction (Fig. 1). However, in some cases the endothermic
interaction is followed by an exothermic reaction after several injec-
tions. The presence of the exothermic and endothermic reactions in
the same injection for POPC:POPG 30:70, at 15 °C and 25 °C, does
not allow the determination of binding parameters accurately from
the “one-site” binding model. For that reason, the model was not
used for those thermograms (Fig. 1). The thermodynamic parametersTable 1







POPC:POPG 70:30 5 71 ± 10 0.150 ± 0.005 (7 ± 1)
15 64 ± 10 0.11 ± 0.01 (1.7 ±
25 65 ± 10 0.070 ± 0.004 (6 ± 3)
POPC:POPG 55:45 5 40 ± 7 0.22 ± 0.02 (7 ± 1)
15 40 ± 5 0.14 ± 0.02 (2 ± 1)
25 42 ± 2 0.110 ± 0.009 (1.4 ±
POPC:POPG 30:70 5 17 ± 1 0.35 ± 0.05 (10 ± 7
15 – – –
25 – – –
LPS 5 0.78 ± 0.03 8.5 ± 0.6 (4.4 ±
15 0.83 ± 0.03 5.6 ± 0.4 (9.88 ±
25 0.72 ± 0.02 6.36 ± 0.06 (8 ± 2)
a Free energies were calculated using the equation ΔG = ΔH – T.ΔS.obtained by the “one-site” ﬁtting model are shown in Table 1 for
POPC:POPG 70:30, 55:45, and 30:70 mixtures. For the remaining
lipid mixtures tested, data could not be ﬁtted due to the lack of inter-
action. A mixture of POPC:POPG 80:20 was also tested, but no heat
was developed during the titration (data not shown). The heat pro-
duction on the rBPI21–membrane interaction studies depends on the
presence of negatively charged POPG (Fig. 1). On the other hand, for
pure POPC bilayers, more similar to eukaryotic membranes, no heat
is developed, conﬁrming the absent or weak (undetectable by the in-
strument) interaction between the AMP and POPC liposomes. Upon
the addition of rBPI21 to the negatively charged membrane model
systems, the heat developed is a sum of several components, namely
those associated with rBPI21–membrane binding, rBPI21–membrane
insertion, lipid–lipid aggregation, membrane perturbation, and rBPI21
conformational changes [37].
In some cases (POPC:POPG 55:45 and 30:70), both endothermic
and exothermic proﬁles were observed. These complex heat ﬂow pro-
ﬁles have been previously observed for other peptide–lipid interac-
tions. Tritrpticin peptide analogs, Tritrp4 and Tritrp6, have the same
proﬁle when interacting with POPE:POPG vesicles [38]. The coexis-
tence of endothermic and exothermic behavior has been considered
to be related to other processes, such as pore formation [39], changes
in the lipid phase properties during titration [40], or initial peptide
aggregation. In order to obtain further information on the interaction
between rBPI21 and membranes, ITC data was used to calculate the
binding isotherm, following the analysis developed by Seelig et al.
[35,36]. The binding isotherm is constructed based on the mole frac-
tion of bound AMP per mole of lipid, Xb, at each injection versus the
equilibrium bulk AMP concentration remaining after each lipid injec-
tion, cf (Fig. 2).
The asymptote represents the maximal AMP interaction with
membranes, accounting for the number of AMP molecules bound per
lipid in a large excess of the former. If the interaction of the AMP and
membrane is entirely hydrophobic in its nature, the relation between
Xb and cf could be expected to be linear, due to a simple partition from
aqueous to lipid phase. This would not be true if rBPI21 self-aggregates.
However, control experiments of rBPI21 dilution upon addition of
buffer produced only minor heat injections always with the same en-
thalpy demonstrating the lower tendency for rBPI21 to form aggre-
gates in the absence of membranes (data not shown). In relation
to the rBPI21–membrane interaction, Fig. 2 shows a deviation from
linearity. This deviation may be attributed to different effects of
rBPI21 at themembrane level. Proteins and peptidesmay inducemem-
brane heterogeneities in the binding site. It is known that POPG may
form clusters in the membranes upon positively charged protein or
peptide interaction [41]. This eventual negatively charged lipid clus-
tering would condition further protein interactions. It is also possible
that the adsorption of the proteins leads to lipid phase separation,
which would interfere with the membrane partition of the protein.







× 104 22.6 ± 0.3 6.28 ± 0.08 −6.13 ± 0.07
0.5) × 105 24.3 ± 0.6 7.0 ± 0.2 −6.9 ± 0.29
× 105 26.6 ± 0.1 7.91 ± 0.02 −7.85 ± 0.02
× 105 28 ± 1 7.7 ± 0.2 −7.5 ± 0.2
× 106 29 ± 1 8. 4 ± 0.4 −8.3 ± 0.4
0.6) × 106 28 ± 1 8.5 ± 0.2 −8.4 ± 0.2
) × 106 33 ± 1 9.2 ± 0.3 −8.8 ± 0.4
– – –
– – –
0.2) × 106 61 ± 1 17.2 ± 0.4 –8.8 ± 0.9
0.01) × 106 51 ± 1 14.6 ± 0.2 −9.0 ± 0.3
× 106 52.8 ± 0.2 15.5 ± 0.2 −9.2 ± 0.2
Fig. 1. ITC experimental data (upper graphs) and the heat of injection obtained by integration of the heat ﬂow peaks as a function of the lipid:rBPI21 molar ratio (lower graphs), at
5 °C, 15 °C and 25 °C, for POPC and POPC:POPG 70:30, 55:45 and 30:70. In all the sets of measurements, 5 mM lipid suspensions (1 mM for POPC:POPG 30:70) were injected into a
1.4485 mL cell containing 5 μM of rBPI21 (for POPC the order of injection was: 5 × 6 μL + 10 × 5 μL + 2 × 15 μL; for POPC:POPG 70:30 and 55:45 it was:
5 × 6 μL + 10 × 5 μL + 5 × 15 μL; and for POPC:POPG 30:70 was: 2 μL + 20 × 10 μL). The same measurements were also conducted for POPC:POPG 80:20. For this case, the
heat ﬂow proﬁles are not shown due to the lack of heat measured during the interaction.
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teraction at higher initial peptide concentrations, and the membranes
become saturated with the AMP, decreasing the electrostatic attrac-
tion. With increasing amounts of lipid, the peptide bulk concentration
decreases and there is an equilibrium distribution of rBPI21 in the
membranes.
The presence of electrostatic interactions or the difference in par-
tition rate toward the different charged vesicles [42] leads to a depen-
dence of the binding constant with the bulk concentration of AMP,
through the relation kbc = Xb/cf (where kbc is the concentration-
dependent binding constant) [38]. This phenomenon is observed on
the studies of rBPI21 interaction with POPC:POPG 70:30 and 55:45,
where the isotherms present a curvature. Taking into account thatonly the external layer of the membrane is exposed for the interaction
when calculating Xb, it is evident that the saturation point for POPC:
POPG 70:30 changes between 25 and 30 mmol of AMP per mol of
lipid, at the temperatures tested. By inverting the values (stoichiometry
of the binding of lipid to the AMP), values between 33 and 40 mol of
lipid per mol of AMP, for one layer, are obtained. The stoichiometries
obtained by the “one-site” binding model (Table 1) for POPC:POPG
70:30 are approximately doubled because the model assumes a bilayer
instead of the external exposed layer. This is also true for POPC:POPG
55:45, where the saturation point is achieved when Xb is between 35
and 50 mmol of AMP per mol of lipid, at the temperatures tested.
This corresponds to a stoichiometry between 20 and 28 mol of lipid
per mol of AMP, assuming only one layer. In this lipid mixture, there
Fig. 2. Binding isotherms calculated from the cumulative heat of reaction of the ITC
thermograms of rBPI21 binding to membranes of POPC:POPG 70:30 (a) and POPC:
POPG 55:45 (b), at 5 °C (circles), 15 °C (triangles) and 25 °C (squares).
2423M.M. Domingues et al. / Biochimica et Biophysica Acta 1828 (2013) 2419–2427is a considerable difference in the saturation point as a function of tem-
perature. At 25 °C, the saturation point is much lower than at 5 °C and
15 °C. The main reason for this may arise from the injection heat pro-
duced during the titrations. At 25 °C, for this mixture, the data wereFig. 3. ITC experimental data (upper graphs) and heat of injection obtained by integration of
5 °C (a), 15 °C (b) and 25 °C (c). In these experiments, aliquots of 38 μM LPS were
2 μL + 27 × 10 μL).very noisy, which may be attributed to other events occurring in the
system, eventually associated with membrane perturbations, such as
loss of membrane integrity, inﬂuencing the binding of rBPI21 to lipids.
ITC experiments were also used to study the interaction between
rBPI21 and LPS, its target molecule in the membrane of Gram-negative
bacteria (Fig. 3). An rBPI21 solution was titrated with LPS aggregates.
The interaction between the AMP and LPS presents a stoichiometry
close to 1:1 (Table 1). The heat proﬁle of the interaction is endothermic,
suggesting that the binding has a considerable entropic nature. The
release of ions from the surface of the LPS might be related to the
endothermic proﬁle of the heat ﬂow. In bacterial membranes, LPS
is cross-associated by the presence of Ca2+ bridging adjacent
molecules [43]. One possible component of the mechanism of action
of rBPI21 in vivomay be to induce the release of Ca2+ from the bacteria
surface, exposing the negative charges of the LPS and its hydrocarbon
chains, which may facilitate the permeation of the peptide across the
bacterial outer membrane [44]. In the range of temperature tested, the
binding is not affected signiﬁcantly. LPS has a phase transition from a
gel-like phase to a ﬂuid phase around 30–37 °C [45]. As LPS maintains
its gel-like phase at 5 °C and 15 °C, the interaction is similar for both
temperatures. The measurements at 37 °C were extremely noisy and,
therefore, they were not completed successfully.
3.2. Differential scanning calorimetry
To further understand rBPI21–membrane interaction, we mea-
sured by DSC the effect of the peptide in the membrane thermotropic
phase transitions of MLV. Two systems were tested: pure DPPC and
DPPC:DPPG 55:45, in the presence of different amounts of rBPI21
(Fig. 4). Both systems have their highly cooperative main phase tran-
sition (Pβ′ → Lα) around 41 °C and a pre-transition related to the
formation of a ripple phase (Lβ′ → Pβ′) approximately at 33 °C, in ac-
cordance with previous reports [46]. For DPPC (Fig. 4a), the mem-
brane structure is not affected by rBPI21 up to 20 μM. This result is
in agreement with the ITC measurements and previous studies
[15,16], where no interaction was observed between the AMP and
POPCmembranes, showing its weak or absent afﬁnity for zwitterionic
membranes. However, with the inclusion of DPPG in the membranes
this is altered, as revealed by the thermograms (Fig. 4b). In thisthe heat ﬂow peaks (bottom graphs) for the interaction of rBPI21 with LPS aggregates, at
injected into a 1.4485 mL cell containing 5 μM rBPI21 (the order of injection was:
Fig. 4. DSC plots of the gel-to-liquid-crystalline phase transition of DPPC (a) and DPPC:
DPPG 55:45 (b), with increasing amounts of rBPI21.
Fig. 5. SAXS curves of POPC:POPG at differentmolar ratios: 100:0 (a), 80:20 (b) and 55:45
(c). Each system was studied in the absence (squares) and presence of 5 μM (circles),
10 μM (upward triangles) and 20 μM (inverted triangles) of rBPI21. All studies were
conducted in the presence of 20 mM sodium phosphate buffer pH 7.4, with 150 mM
NaCl. Fitting parameters are presented in Table 2.
2424 M.M. Domingues et al. / Biochimica et Biophysica Acta 1828 (2013) 2419–2427mixture, it is also possible to observe two pre-transitions. It could be
reasoned that the existence of two pre-transitions may indicate a
non-ideal phase coexistence between DPPC and DPPG. Nevertheless,
it is described in the literature that DPPC and DPPG tend to mix uni-
formly at any ratios, with close to ideal behavior, despite the net neg-
ative charge of DPPG [47]. The pre-transition at ~23 °C is commonly
named subtransition and its molecular details are not very well un-
derstood. Due to the time-dependent characteristics of this transition,
it is not useful for analytical purposes and, therefore, it was not con-
sidered in the analysis [48]. On the other hand, the pre-transition
related to the gel to ripple phase formation is useful for analytical
considerations, because it is very sensitive to the presence of impuri-
ties, such as small molecules and, in this case, the presence of rBPI21.
By increasing rBPI21 concentration, the enthalpy of the pre-transition
decreases, while the temperature of the pre-transition increases. At
the highest AMP concentration studied, 20 μM, only a shoulder re-
mains in the region of the pre-transition. Furthermore, at this concen-
tration, an increase of 1 °C in the phase transition temperature occurs.
The increase in both the pre-transition and main transition tempera-
tures indicates a stabilization of the gel phase (Lβ′) upon binding of
rBPI21. Due to the positive charge of the AMP, the negative charge
from DPPG is probably screened, decreasing the electrostatic repulsion
between DPPG molecules, ensuring a better packing of the lipid and,
consequently, an increase of the van der Waals attraction between
lipid molecules, rigidifying the membrane and culminating in a minor
increase in the phase transition temperature [46]. Despite the electro-
static screening of DPPG molecules, hydrophobic interaction betweenhydrocarbon chains and rBPI21 can also be related to the increase of
the melting temperature of the membrane model system. As seen for
a peptide enriched in Leu-Lys amino acid residues [49], the results
obtained suggest a possible segregation of lipid domains enriched in
PG, promoted by rBPI21, culminating in a better packing of PG mole-
cules. Also, the larger effects on the DPPC:DPPG 55:45 system indicate
that the negative charge is extremely important for the interaction of
rBPI21 with membranes, as previously suggested [15,16], correlating
with the lower activity in mammalian cells (neutral membranes)
while inhibiting bacterial growth (negatively charged membranes).
3.3. Small angle X-ray scattering
Fig. 5a shows the SAXS curves of LUV composed of POPC in the ab-
sence and presence of rBPI21 5, 10, and 20 μM. The curves are typical
of the scattering from unilamellar vesicles, with a broad peak at
q ~ 0.11 Å−1 [27]. The addition of increasing amounts of rBPI21 does
not affect signiﬁcantly the bilayer proﬁle. There is a good ﬁtting of
the bilayer structural model (Eqs. (2)−(3); solid lines on Fig. 5a) to
the experimental data. The ﬁtting parameters are presented in
Table 2 and reveal that the addition of the AMP does not alter the
main features of the hydrophobic environment of the zwitterionic
membrane. In fact, just a small increase in the polar head thickness
from 6.7 Å to 7.2 Å, accompanied by a small decrease in the polar
electron density from 0.45 to 0.42 e/Å3, was observed in the presence
of 20 μM rBPI21 (Table 2). Therefore, the AMP must reside close to the
polar head region of the lipid membrane, without affecting signiﬁ-
cantly the inner region of the bilayer. This can be correlated with
rBPI21 weak interaction with the zwitterionic system.
For systems containing the negatively charged lipid POPG, up to
three well-deﬁned Bragg peaks appear in the scattering curves when
the concentration of the AMP increases, as shown in Fig. 5b–c. This ef-
fect is more pronounced when the concentration of the rBPI21 reaches
20 μM, where the SAXS curves indeed are typical of the formation
of well-ordered MLV [50]. To quantify and better investigate the
main features of such structures, the MCT theory was applied to the
Table 2
Fitting parameters obtained for the lipid systems composed of POPC or POPC:POPG (80:20 or 55:45) and increasing amounts of rBPI21 in 20 mM sodium phosphate buffer pH 7.4,
containing 150 mM NaCl. Rpol, polar head thickness; Rpar, acyl chain length; RCH3, methyl length; ρpol, ρpar, ρCH3, respective electron densities; ηCaillé, Caillé parameter; N and DLamella,
number and average distance of bilayers in one-dimensional lamellar stacking, respectively; σCaillé, mean-square nearest neighbor distance ﬂuctuations calculated through Eq. (5);
w, weight of MLV contribution to the total scattering (Eq. (1)).
LUV MLV
POPC
[rBPI21] (μM) 0 5 10 20 0 5 10 20
Rpol (Å) 6.7 ± 0.3 7.3 ± 0.4 7.1 ± 0.4 7.2 ± 0.4 – – – –
Rpar (Å) 11.3 ± 0.8 11.3 ± 0.8 11.3 ± 0.8 11.3 ± 0.8 – – – –
RCH3 (Å) 3.5 ± 0.2 3.5 ± 0.2 3.5 ± 0.2 3.5 ± 0.2 – – – –
ρpol (e/Å3) 0.45 ± 0.01 0.43 ± 0.01 0.43 ± 0.01 0.42 ± 0.01 – – – –
ρpar (e/Å3) 0.30 ± 0.01 0.30 ± 0.01 0.30 ± 0.01 0.30 ± 0.01 – – – –
ρCH3 (e/Å3) 0.22 ± 0.01 0.22 ± 0.01 0.22 ± 0.01 0.22 ± 0.01 – – – –
POPC:POPG 80:20
[rBPI21] (μM) 0 5 10 20 0 5 10 20
w (%) 2.0 ± 0.2 3.5 ± 0.4 6.3 ± 0.7
Rpol (Å) 9.7 ± 0.8 9.6 ± 0.7 9.5 ± 0.6 8.5 ± 0.7 – 9.6 ± 0.8 9.5 ± 0.6 8.5 ± 0.6
Rpar (Å) 9.8 ± 0.8 9.8 ± 0.8 9.8 ± 0.8 9.8 ± 0.8 – 9.8 ± 0.8 9.8 ± 0.8 9.8 ± 0.8
RCH3 (Å) 3.4 ± 0.2 3.4 ± 0.2 3.4 ± 0.2 3.4 ± 0.2 – 3.4 ± 0.2 3.4 ± 0.2 3.4 ± 0.2
ρpol (e/Å3) 0.41 ± 0.01 0.40 ± 0.01 0.40 ± 0.01 0.40 ± 0.01 – 0.40 ± 0.01 0.40 ± 0.01 0.40 ± 0.01
ρpar (e/Å3) 0.29 ± 0.01 0.29 ± 0.01 0.29 ± 0.01 0.29 ± 0.01 – 0.29 ± 0.01 0.29 ± 0.01 0.29 ± 0.01
ρCH3 (e/Å3) 0.24 ± 0.01 0.24 ± 0.01 0.24 ± 0.01 0.24 ± 0.01 – 0.24 ± 0.01 0.24 ± 0.01 0.23 ± 0.01
N – – – – – 2 ± 1 5 ± 1 7 ± 1
ηCaillé – – – – – 0.18 ± 0.02 0.18 ± 0.02 0.18 ± 0.02
DLamella (Å) – – – – – 112 ± 5 112 ± 5 110 ± 5
σCaillé (Å) – – – – – 14.0 ± 0.8 14.0 ± 0.8 13.8 ± 0.8
POPC:POPG 55:45
[rBPI21] (μM) 0 5 10 20 0 5 10 20
w (%) 6 ± 1 8 ± 1 12 ± 2
Rpol (Å) 9.4 ± 0.6 8.2 ± 0.6 6.5 ± 0.5 6.5 ± 0.5 – 8.2 ± 0.7 6.5 ± 0.6 6.5 ± 0.5
Rpar (Å) 11.2 ± 0.7 11.2 ± 0.7 12.1 ± 0.7 10.7 ± 0.7 – 11.2 ± 0.5 12.1 ± 0.7 10.7 ± 0.7
RCH3 (Å) 3.0 2.8 ± 0.3 2.3 ± 0.2 2.3 ± 0.2 – 2.8 ± 0.3 2.3 ± 0.3 2.3 ± 0.2
ρpol (e/Å3) 0.43 ± 0.01 0.39 ± 0.01 0.40 ± 0.01 0.40 ± 0.01 – 0.39 ± 0.01 0.40 ± 0.01 0.40 ± 0.01
ρpar (e/Å3) 0.31 ± 0.01 0.31 ± 0.01 0.31 ± 0.01 0.31 ± 0.01 – 0.31 ± 0.01 0.31 ± 0.01 0.30 ± 0.01
ρCH3 (e/Å3) 0.17 ± 0.01 0.18 ± 0.01 0.18 ± 0.01 0.25 ± 0.01 – 0.18 ± 0.01 0.18 ± 0.01 0.25 ± 0.01
N – – – – – 3 ± 1 5 ± 1 8 ± 1
ηCaillé – – – – – 0.085 ± 0.003 0.085 ± 0.003 0.085 ± 0.003
DLamella (Å) – – – – – 114 ± 5 111 ± 5 107 ± 5
σCaillé (Å) – – – – – 9.8 ± 0.6 9.6 ± 0.6 9.2 ± 0.6
2425M.M. Domingues et al. / Biochimica et Biophysica Acta 1828 (2013) 2419–2427data analysis and the percentage of LUV coexisting with MLV was
evaluated for each studied membrane composition, using Eq. (1).
The structural parameters of the lipid bilayer composed of POPC:
POPG in the absence of rBPI21 are very similar to those found in the
POPC LUV, except for the polar head thickness that resulted to be
circa 3 Å-thicker (Table 2). Concerning the POPC:POPG 80:20 mem-
brane, the interaction with rBPI21 does not induce any signiﬁcant
change on the lipid bilayer dimensions. Interestingly, the interaction
of the peptide with such a membrane containing 20 mol% of negative
phospholipids promotes the formation of a small population of MLV
coexisting with LUV. In fact, circa 2% up to 7% of MLV (w1 in Eq. (1);
Table 2) are formed and contribute to the total scattering intensity
when the membrane is in contact with 5 to 20 μM of rBPI21, respec-
tively. It should be noted, however, that MLV are composed of a
small number of repeating units (up to N = 7 for POPC:POPG 80:20
mixed membranes in the presence of 20 μM rBPI21; Table 2).
The interaction between rBPI21 and POPC:POPG 55:45 membranes
causes a decrease in the polar head thickness, with a reduction of the
respective polar electron density, as well as a shrinkage in the hydro-
phobic moiety. Therefore, the thickness of the bilayer containing 45%
of negative phospholipids is reduced from 47 ± 2 Å to 40 ± 2 Å
when in contact with 20 μM rBPI21.
Concomitantly, the percentage of MLV increases for such system
in respect to the membrane with a lower amount of POPG, such
that the weight of the multilayer scattering to the total scattering in-
tensity,w1 (Eq. (1), Table 2), increases from 6% to 12% in the presence
of 5 and 20 μM of rBPI21, respectively. Note, however, that the MLV
present a small number of stacking layers, N, too (Table 2). Therefore,
the SAXS results give support to the conclusion that the peptideimpacts to a larger extent on POPC:POPG 55:45 membranes than it
does on POPC:POPG 80:20, in good agreement with ITC and DSC
results.
Furthermore, another main difference between the peptide inter-
action with POPC:POPG 80:20 and 55:45 is reﬂected in the ηCaillé
value, which decreases as the percentage of anionic lipid increases
(Table 2). As a consequence, POPC:POPG 80:20 membranes have
a higher σCaillé value (~14.0 Å) than that observed for POPC:POPG
55:45 (~9.5 Å), regardless of the rBPI21 concentration (Table 2).
Such a result indicates that the interaction between the positively
charged AMP and membranes with a higher negative charge reduces
membrane ﬂuctuations to a larger extent. This leads to a more rigid
membrane, as also observed by DSC.
The number of stacked bilayers, N (Table 2), is independent of the
total charge on themembrane surface, being only inﬂuenced by rBPI21
concentration. For the studied POPC:POPG membranes, 20 μM of the
AMP is able to induce the formation of 7 ± 1 multilayers, with a
mean distance between two adjacent bilayers, DLamella, of ~108 ±
6 Å (Table 2). Since the lipid bilayer thickness varies between 50 and
40 Å in the absence and presence of the AMP (Table 2), rBPI21 must
reside between two adjacent bilayers, probably interacting with
both chargedmembrane surfaces. Recently, Trusova et al. [51] studied
the effect of lysozyme (a 18 kDa protein) on the morphology of
solid-supported lipid bilayers composed of a zwitterionic lipid (PC)
in the absence and presence of an anionic lipid (cardiolipin, CL). These
authors showed that lysozyme was able to induce the formation of
lipid multilamellar stacking, with a DLamella on the 90–105 Å range.
Interestingly, lysozyme and rBPI21 have similar molecular weights
(18 and 21 kDa, respectively).
2426 M.M. Domingues et al. / Biochimica et Biophysica Acta 1828 (2013) 2419–2427In conclusion, rBPI21 was shown to be able to interact with mem-
brane model systems when negatively charged phospholipids are
present, changing the membrane organization. The interaction is
followed bymembrane structure alterations, with the AMP promoting
the formation of multilamellar arrangements. Taken together, the ob-
servations for the interaction of rBPI21 withmembranemodel systems
reinforce the proposed mechanism of action of this microbicide agent
against Gram-negative bacteria, at the membrane level [15]. In a ﬁrst
step, the peptide seems to be attracted by the negative charge of the
LPS to the surface of the bacteria, partitioning to the LPS-rich outer
monolayer of the bacteria outer membrane and allowing the peptide
to enter in the periplasmic space. There, the negative charges of the
phospholipids, both from the inner membrane and from the inner
leaﬂet of the outer membrane (both rich in phosphatidylglycerol)
can contribute to the interaction with the peptide. This process
would bring together the two membranes of Gram-negative bacteria,
inducing their partial or total coalescence, leading to increased perme-
ability, eventual disruption and cell death.
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